Company Filing History:
Years Active: 2023
Title: Randi Barbara Gombos: Innovator in Antibody Development
Introduction
Randi Barbara Gombos is a notable inventor based in Wilmington, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target human CD96. Her work has implications for therapeutic applications, showcasing her innovative spirit and dedication to advancing medical science.
Latest Patents
Randi holds 1 patent for her invention titled "Antibodies that specifically bind human CD96." This patent provides antibodies that specifically bind to CD96 and antagonize its function. The disclosure also includes pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors, and host cells for producing these antibodies. Furthermore, it outlines methods for treating subjects using these antibodies, highlighting the potential impact of her work in therapeutic settings.
Career Highlights
Randi is currently associated with Agenus Inc., a company focused on developing innovative immunotherapies. Her role at Agenus allows her to contribute to cutting-edge research and development in the field of immunology. Her expertise and innovative approach have positioned her as a valuable asset in her organization.
Collaborations
Randi collaborates with talented individuals such as Dhan Sidhartha Chand and Olga Ignatovich. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in biotechnology.
Conclusion
Randi Barbara Gombos exemplifies the spirit of innovation in the biotechnology sector. Her work on antibodies targeting human CD96 represents a significant advancement in therapeutic development. Through her contributions, she continues to influence the field and inspire future innovations.